Relmada Therapeutics Inc (RLMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2016 | 06-2015 | 06-2014 | 12-2013 | 06-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,500 | 22,470 | 25,564 | 3,523 | N/A |
| Receivables | 232 | N/A | N/A | N/A | N/A |
| Other current assets | 0 | 0 | 0 | 79 | 0 |
| TOTAL | $9,298 | $23,968 | $25,743 | $3,612 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 531 | 24 | 10 | 9 | N/A |
| Other Non-Current Assets | 414 | 401 | 12 | 12 | 0 |
| TOTAL | $946 | $425 | $22 | $21 | $N/A |
| Total Assets | $10,244 | $24,393 | $25,765 | $3,632 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,260 | 835 | 746 | 180 | 0 |
| Accrued Expenses | 635 | 482 | 382 | 439 | N/A |
| Other current liabilities | 893 | 14,001 | 25,587 | 20,103 | N/A |
| TOTAL | $3,061 | $15,583 | $26,773 | $21,481 | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 141 | 0 | 100 | 100 | 0 |
| TOTAL | $141 | $N/A | $100 | $100 | $N/A |
| Total Liabilities | $3,202 | $15,583 | $26,873 | $21,581 | $N/A |
| Shareholders' Equity | |||||
| Common Shares | 12 | 11 | 8 | 5 | N/A |
| Retained earnings | -79,097 | -76,122 | -55,319 | -33,983 | N/A |
| Other shareholders' equity | 0 | 0 | 1 | 0 | 14 |
| TOTAL | $7,042 | $8,810 | $-1,109 | $-17,949 | $14 |
| Total Liabilities And Equity | $10,244 | $24,393 | $25,764 | $3,632 | $14 |